Position in JNJ
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$2,755,828
+$261,074 QoQ
Shares Held
10,851
+6.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#2,062
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cooper Financial Group holds $19,451,562 across 11 Drug Manufacturers - General names. JNJ ranks #4 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,274 | $6,325,794 | |
| 2 | AMGN |
Amgen Inc
|
8,265 | $2,992,921 | |
| 3 | ABBV |
AbbVie Inc.
|
11,460 | $2,883,794 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
10,851 | $2,755,828 | |
| 5 | AZN |
Astrazeneca PLC
|
6,342 | $1,202,570 | |
| 6 | MRK |
Merck & Co., Inc.
|
8,089 | $1,039,436 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
12,387 | $713,738 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,403 | $556,275 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,755,828 | 10,851 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $2,494,754 | 10,206 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,892,557 | 9,145 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $1,620,385 | 8,739 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,329,841 | 8,706 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $1,909,813 | 11,516 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,511,134 | 10,449 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $1,624,975 | 10,027 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,416,436 | 9,691 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,531,595 | 9,682 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,497,807 | 9,556 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,444,737 | 9,276 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,607,364 | 9,711 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $1,543,490 | 9,958 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,764,026 | 9,986 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,583,775 | 9,695 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,826,755 | 10,291 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $1,680,849 | 9,484 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,542,709 | 9,018 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,585,768 | 9,819 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $1,627,795 | 9,881 | Shares | Sole | 2021-07-12 | |
| 2021-03-31 | $1,836,282 | 11,173 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,918,147 | 12,188 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,420,910 | 9,544 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,346,813 | 9,577 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,160,500 | 8,850 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||